Register Here

2018 Executive Sponsors

BD Medical

2018 Associate Sponsors


2018 Technology Sponsors

Adare Pharmaceuticals
Cambridge Design Partnership
Credence medsystems
Common Sensing
Enable Injections
Harro Höfliger Verpackungsmaschinen GmbH
InnoCore Pharmaceuticals
leon nanodrugs
Portal Instruments
Quantex Vernay
Recro Gainsville
Sorrel Medical

2018 Exhibitors

Baumann Group
DS Technology
NN Life Sciences
Stevanato Group
Team Consulting

2018 Soapbox Sponsors

Cam Med
Cinti Medical, Inc

2018 Media Partners

Drug Development & Delivery
Med Device Online
Pharmaceutical Online
SciDoc Publishers
Technology Networks


PODD Retrospective

We are gearing up for the 8th Annual Partnership Opportunities in Drug Delivery (PODD) conference, where you can expect to meet the widest range of drug delivery technologies with ample networking and partnering.

This annual Boston-based conference is designed with three purposes:

PODD Audience Web

  1. To present a strategic level program for pharma and biotech scientists and business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
  2. To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are.
  3. To offer ample networking time, facilities and services for one-on-one meetings to establish new business contacts and enhance existing ones.

The 8th annual event is chaired by Dr Barbara Lueckel, Global Business Development Director, Roche Partnering Innovation at Roche. 

2018 Featured Keynotes already confirmed include:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
Amy Schulman
, Co-founder and CEO, Lyndra and Partner at Polaris
Jeffrey Karp, PhD
, Associate Professor of Medicine, Harvard Medical School
Justin Wright, PhD
, Global Head of Innovation, Novartis

We are delighted to announce the 2018 Track Chairs:
Nima Akhavein, PhD, Associate Fellow and Scientific Leader, GSK
Ulrich Bruggemann, Head Academics and Innovation, Global Medical Devices Development, Sanofi US
Mathias Romacker, Senior Director, Device Strategy, Pfizer
Michael Cucolo, Director of Business Development, BMS

Take advantage of the launch discount and let us know if you have any questions.

An Insight into PODD



Valerie Bowling New

Valerie Bowling
Executive Director


Meredith Sands
Executive Director, Business Development

Michelle McDermott
Conference Producer

Kimberly Chin
Marketing Director

Geeta Bachani
Business Development Manager


Meg Gould
Conference Planner


  • "I really enjoyed the PODD event once again. The team continue to bring the very best content to the event. The venue was spectacular and the organization impeccable. I thoroughly enjoyed it and thanks again for having me on the agenda."

    - Keith Horspool, PhD, Boehringer Ingelheim

  • "Excellent PODD conference."

    - James Spavins, formerly of Pfizer

  • "Was a great conference and getting better every year!"

    - Rudy Emmelot, IntraTab Labs

  • "I have to say PODD was a great opportunity for me. I learned a lot and met great people. Thanks to The Conference Forum."

    - Sina Eetezadi, Roche Pharmaceuticals

  • "I found the conference very insightful and the one-to-one meetings highly valuable.  Congratulations on organizing a wonderful conference!"

    - Mary Gardner, Hospira Inc.

  • "We were impressed by the size of the turn out, the caliber of the individuals in attendance and the quality of the panels, presentations and discussions. It was a pleasure and privilege for us to attend. We only hope that our presence added to your conference as much as your conference added to our position in the pharma community. The conference team consistently got "right" both the technicalities, as well as the personalities.  Great job, well done. Congratulations, and kudos, to all of you."

    - Susan Rosenbaum, Lauren Sciences LLC

  • "A nice and fruitful meeting."

    - Sylvestre Grizot, PhD, MedinCell S.A.

  • "I enjoyed the opportunity and the new connections I made.  I look forward to next year’s event."

    - Jonathan Behr, PhD, Partners Healthcare

  • " Very much enjoyed both the 1st and 2nd PODD meetings - and looking forward to the 3rd in Boston next year. Great forum for anyone interested in drug delivery for the biopharma industry"

    - Baruch Harris, PhD, Forum Pharmaceuticals

  • "Overall, outstanding conference, well done!"

    - Ralph Solarski, PhD, Kimberly-Clark Corporation

  • "Congratulations on a very successful conference! It is a very unique conference and I enjoyed it very much."

    - Avinash G. Thombre, PhD, Pfizer Inc.

  • "Great conference!"

    - Jones W. Bryan, PhD, Supernus Pharmaceuticals

  • "Thank you for a great conference that brought us together to network and share ideas. The conference is refreshing and well organized. Congratulations for a job well done."

    - Peter Hoffmann, PhD, ph Associates

  • "I enjoyed the panels and the meeting was well done."

    - Jack Talley, EpiCept Corp.

  • "Nice job!! Thanks to the conference organizers."

    - Jonathan M. Rigby, SteadyMed Therapeutics, Inc.

  • "Thank you for an excellent conference."

    - Jane Nichols, MBA, Nanocopoeia Inc.

  • "I enjoyed the conference and received a number of interesting leads from it."

    - Julius Knowles, Novartis Institutes for BioMedical Research, Inc.

  • "I was honestly very much impressed by the conference, the set up with presentations and panels and the high level number of executives from the different stakeholders."

    - Sven Stegemann, PhD, Geriatric Medicine Society

  • "It was a great event and my thanks to you and your excellent team."

    - Keith Horspool, PhD, Boehringer Ingelheim

  • "It was a great pleasure to attend PODD.  Thank for organizing this meeting."

    - Ye (Bill) Huang, PhD, Global Pharmaceutical Science

  • "I thoroughly enjoyed the conference, the meetings and the presentations."

    - Monica Fernand, BD Medical – Pharmaceutical Systems